...endothelial cells to diagnose colorectal cancer LICENSING STATUS: Patent and licensing status unavailable PUBLICATION DETAILS: Cima...

...al. Proc. Natl. Acad. Sci. USA; published online April 21, 2014; doi:10.1073/pnas.1400015111 Contact: Michael J. Cima...

...Fentanyl effervescent buccal tablet (formerly OVF) Fast-dissolve transmucosal formulation of fentanyl Cancer pain Filed (Japan) Cima Labs Inc....

...and director of hepatology and gene therapy at the university's Centre for Applied Medical Research (CIMA...
...the use of CT-1 in liver indications. Digna has licensed new patents filed by the CIMA...

...Boston, Mass. e-mail: ron_depinho@dfci.harvard.edu Contact: Lynda Chin, same affiliation as above e-mail: lynda_chin@dfci.harvard.edu 2. Cima...

...4(9); doi:10.1038/scibx.2011.269 Published online March 3, 2011 Patent application filed; licensed exclusively to ProteoMediX AG Cima...

...and a director, formerly general manager and VP of worldwide drug delivery technologies at the Cima Labs Inc....

...a director. Duddu was formerly general manager and VP of worldwide drug delivery technologies at Cima Labs Inc....

...Michael Cima, Robert Langer and Christine Bunt formed newco Taris to develop drug delivery devices. Taris...
...interstitial cystitis/painful bladder syndrome. Taris plans to begin Phase I testing of LiRIS this year. Cima...

...with Fentora , a buccal fentanyl tablet that it gained via the 2004 acquisition of Cima...